Parathyroid Carcinoma: Diagnosis and Treatment



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This paper describes the diagnostic search, treatment, and follow-up of a patient with parathyroid carcinoma. The authors analyzed the clinical signs and results of the investigations. Despite the long-term clinical presentation of urolithiasis, parathyroid hyperfunction was not suspected. Hyperparathyroidism was detected only when damage to the musculoskeletal system became clinical. The differential diagnoses included parathyroid carcinoma, iliac osteosarcoma, and anterior mediastinal tumor. The main difficulty in the verification of the diagnosis in this case was the atypical localization of the affected parathyroid gland. Conventional imaging is not effective in detecting this location of parathyroid carcinoma. Parathyroidectomy allowed for the final diagnosis of parathyroid carcinoma. Follow-up of the case after surgery revealed improvement, including less pain, improvement in parathyroid hormone and calcium levels, restoration of the iliac cortex, and reossification of the brown tumor. In general, this patient exhibited signs suggestive of parathyroid carcinoma, including very high parathyroid hormone and calcium levels, simultaneous renal and bone involvement, and a large mediastinal mass together with high corrected calcium levels. However, because the disease is rare and the tumor had an atypical localization, the diagnostic search for the tumor was long. The authors highlight the importance of early detection and a multidisciplinary approach for improving the prognosis of patients with this rare condition.

About the authors

Maxim V. Matyanin

City Hospital № 33 of the Leninsky District of Nizhny Novgorod

Email: matyanin@list.ru
ORCID iD: 0009-0001-5640-7702
SPIN-code: 5958-5280

MD, Cand. Sci. (Medicine), Surgeon, Depart. of Surgery № 1

Russian Federation, Nizhny Novgorod

Natalya V. Zhdankina

Lobachevsky State University of Nizhny Novgorod

Author for correspondence.
Email: zhdankina@unn.ru
ORCID iD: 0000-0003-1109-3268
SPIN-code: 1730-0095

MD, Cand. Sci. (Medicine), Assistant Professor, Depart. of Internal Diseases

Russian Federation, Nizhny Novgorod

Pavel S. Zubeev

City Hospital № 33 of the Leninsky District of Nizhny Novgorod

Email: mlpu33@mail.ru
ORCID iD: 0000-0003-0414-9104
SPIN-code: 7091-8394

MD, Dr. Sci. (Medicine), Chief Medical Officer

Russian Federation, Nizhny Novgorod

References

  1. Cetani F, Pardi E, Marcocci C. Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone. Endocrinol Metab Clin North Am. 2021;50(4):683–709. doi: 10.1016/j.ecl.2021.07.001 EDN: RYTSJU
  2. Kubal M, Lech M, Lajeunesse-Trempe F, et al. Advances in the management of parathyroid carcinoma. Mol Cell Endocrinol. 2024;592:112329. doi: 10.1016/j.mce.2024.112329 EDN: UEGVLT
  3. Cetani F, Pardi E, Cetani CM, et al. Parathyroid carcinoma: a clinical and genetic perspective. Minerva Endocrinol. 2018;43(2):144–155. doi: 10.23736/S0391-1977.17.02737-7
  4. Kumar A, Balbach J. Inactivation of parathyroid hormone: perspectives of drug discovery to combating hyperparathyroidism. Curr Mol Pharmacol. 2022;15(2):292–305. doi: 10.2174/1874467214666210126112839 EDN: CYEQUY
  5. Ullah A, Khan J, Waheed A, et al. Parathyroid carcinoma: incidence, survival analysis, and management: a study from the SEER database and insights into future therapeutic perspectives. Cancers. 2022;14(6):1426. doi: 10.3390/cancers14061426 EDN: HAACGG
  6. Ferraro V, Sgaramella LI, Di Meo G, et al. Current concepts in parathyroid carcinoma: a single Centre experience. BMC Endocr Disord. 2019;19(Suppl 1):46. doi: 10.1186/s12902-019-0368-1 EDN: ZYGLND
  7. Machado NN, Wilhelm SM. Parathyroid cancer: a review. Cancers. 2019;11(11):1676. doi: 10.3390/cancers11111676 EDN: JJBADY
  8. Takumi K, Fukukura Y, Hakamada H, et al. CT features of parathyroid carcinomas: comparison with benign parathyroid lesions. Jpn J Radiol. 2019;37(5):380–389. doi: 10.1007/s11604-019-00825-3 EDN: BUMHYL
  9. Morris MA, Saboury B, Ahlman M, et al. Parathyroid imaging: past, present, and future. Front Endocrinol. 2022;12:760419. doi: 10.3389/fendo.2021.760419 EDN: TYFUPO
  10. Do Cao C, Aubert S, Trinel C, et al. Parathyroid carcinoma: diagnostic criteria, classification, evaluation. Ann Endocrinol. 2015;76(2):165–168. doi: 10.1016/j.ando.2015.03.016
  11. Cetani F, Pardi E, Liborio Torregrossa L, et al. Approach to the patient with parathyroid carcinoma. J Clin Endocrinol Metab. 2023;109(1):256–268. doi: 10.1210/clinem/dgad455 EDN: NDXHIA
  12. Garrigues G, Batisse-Lignier M, Uhrhammer N, et al. Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: a case report and review of the literature. Mol Genet Genomic Med. 2023;11(5):e2133. doi: 10.1002/mgg3.2133 EDN: EPINVV
  13. Su C, Zhang J, Yang H, et al. Diagnosis and treatment of liver metastases of parathyroid carcinoma. Front Endocrinol. 2022;13:982972. doi: 10.3389/fendo.2022.982972 EDN: IYVGNM
  14. Carsote M, Nistor C. Forestalling hungry bone syndrome after parathyroidectomy in patients with primary and renal hyperparathyroidism. Diagnostics. 2023;13(11):1953. doi: 10.3390/diagnostics13111953 EDN: COEVKK
  15. Roser P, Leca BM, Coelho C, et al. Diagnosis and management of parathyroid carcinoma: a state-of-the-art review. Endocr Relat Cancer. 2023;30(4):e220287. doi: 10.1530/ERC-22-0287 EDN: OOPFFI
  16. Wang L, Han D, Chen W, et al. Non-functional parathyroid carcinoma: a case report and review of the literature. Cancer Biol Ther. 2015;16(11):1569–1576. doi: 10.1080/15384047.2015.1070989
  17. Zhou P, Xu j, Guo Y, et al. The role of anatomical and functional orientation in identification of parathyroid glands for patients with parathyroidectomy. Front Endocrinol. 2024;15:1428669. doi: 10.3389/fendo.2024.1428669 EDN: OUJEWX
  18. Uslu A, Okut G, Tercan IC, et al. Anatomical distribution and number of parathyroid glands, and parathyroid function, after total parathyroidectomy and bilateral cervical thymectomy. Medicine. 2019;98(23):e15926. doi: 10.1097/MD.0000000000015926
  19. Schulte KM, Galatá G, Talat N. Mediastinal parathyroid cancer. Cancers. 2022;14(23):5852. doi: 10.3390/cancers14235852 EDN: IKKYQQ
  20. McInerney NJ, Moran T, O'Duffy F. Parathyroid carcinoma: current management and outcomes — a systematic review. Am J Otolaryngol. 2023;44(4):103843. doi: 10.1016/j.amjoto.2023.103843 EDN: DOOKCM
  21. Wei B, Zhao T, Shen H, et al. Extended en bloc reoperation for recurrent or persistent parathyroid carcinoma: analysis of 31 cases in a single institute experience. Ann Surg Oncol. 2022;29(2):1208–1215. doi: 10.1245/s10434-021-10962-7 EDN: BPMYTG
  22. Roser P, Leca BM, Coelho C, et al. Diagnosis and management of parathyroid carcinoma: a state-of-the-art review. Endocr Relat Cancer. 2023;30(4):e220287. doi: 10.1530/ERC-22-0287 EDN: OOPFFI

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2025 Eco-Vector